Abby Timmons
Associate
Orange County
abby.timmons@lw.com
+1.714.755.8161
PRACTICES
- Capital Markets
- Mergers & Acquisitions
INDUSTRIES
- Healthcare & Life Sciences
- REITs
- Technology
EDUCATION
- JD, Notre Dame Law School, 2019
summa cum laude - BA in Professional Writing, Purdue University, 2016
LANGUAGES SPOKEN
- English
PROFILE
Abby Timmons is an associate in the Orange County office of Latham & Watkins and a member of the Corporate Department.
Abby represents both public and private companies, particularly in the REIT, life sciences, and technology industries. She advises clients across a broad range of corporate transactions, including mergers and acquisitions, capital markets transactions, and general corporate matters.
In addition to her commercial work, Abby maintains a pro bono practice and serves on Latham’s Training and Career Enhancement (TACE) committee, particularly supporting the firmwide training program, Latham & Watkins University. She also previously served as a judicial clerk to Vice Chancellor Glasscock III of the Delaware Court of Chancery.
EXPERIENCE
Abby’s representative experience, with an emphasis on mergers & acquisitions work, includes advising on the following transactions:
- Skydance Media, LLC in its pending US$28 billion merger with Paramount Global
- Amphenol Corporation in its US$2.025 billion acquisition of the Carlisle Interconnect Technologies business segment
- Amphenol Corporation in its US$140 million acquisition of PCTEL, Inc.
- CoStar Group, Inc. in its pending US$2.1 billion acquisition of Matterport, Inc.
- Realty Income Corporation in connection with capital markets matters relating to its acquisition of Spirit Realty Capital, Inc.
- Icosavax, Inc. in its US$1.1 billion sale to AstraZeneca plc
- Nevro Corp. in its US$40 million acquisition of Vyrsa Technologies
- Convex Labs in its sale to ServiceTitan
- INDUS Realty Trust, Inc. in its US$868 million acquisition by Centerbridge and GIC
- Hersha Hospitality Trust in connection with capital markets matters relating to its US$1.4 billion acquisition by KSL Capital Partners
- Prometheus Biosciences, Inc. in its US$10.8 billion acquisition by Merck & Co., Inc.
- Ouster, Inc. in its US$400 million merger of equals with Velodyne Lidar, Inc.
- AEON Biopharma, Inc. in connection with capital markets matters relating to its business combination with Priveterra Acquisition Corp.
- Ouster, Inc. in its US$1.9 billion business combination with Colonnade Acquisition Corp.
- Planet Labs in its US$2.8 billion business combination with dMY Technology Group, Inc. IV
- Realty Income Corporation in its acquisition of VEREIT, Inc.
- The underwriters in the initial public offering of Intapp, Inc.
- Numerous follow-on offerings for public companies, especially in the REIT and life sciences industries